Increased serum clearance of oligomannose species present on a human IgG1 molecule. - Wikidata - awgldk - TriplyDB

Increased serum clearance of oligomannose species present on a human IgG1 molecule.

Increased serum clearance of oligomannose species present on a human IgG1 molecule.

http://www.wikidata.org/entity/Q36402812

about

Fc glycans of therapeutic antibodies as critical quality attributes In vitro and in vivo modifications of recombinant and human IgG antibodies Chemical and Structural Analysis of an Antibody Folding Intermediate Trapped during Glycan Biosynthesis Biochemical Characterization of Human Anti-Hepatitis B Monoclonal Antibody Produced in the Microalgae Phaeodactylum tricornutum Consistency of quality attributes for the glycosylated monoclonal antibody Humira® (adalimumab).High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation.High-throughput glycosylation analysis of therapeutic immunoglobulin G by capillary gel electrophoresis using a DNA analyzer N-glycan PK Profiling Using a High Sensitivity nanoLCMS Work-Flow with Heavy Stable Isotope Labeled Internal Standard and Application to a Preclinical Study of an IgG1 Biopharmaceutical.Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles--part 1: separation-based methods Time-Dependent Structural Alteration of Rituximab Analyzed by LC/TOF-MS after a Systemic Administration to Rats.Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori).Proposed mechanism of off-target toxicity for antibody-drug conjugates driven by mannose receptor uptake.Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.The Emerging Importance of IgG Fab Glycosylation in Immunity.Impact of IgG Fc-Oligosaccharides on Recombinant Monoclonal Antibody Structure, Stability, Safety, and Efficacy.Glycosylation of monoclonal antibody products: Current status and future prospects.Impact of cell culture on recombinant monoclonal antibody product heterogeneity.Modulators of IgG penetration through the blood-brain barrier: Implications for Alzheimer's disease immunotherapy.Marketing approval of mogamulizumab: a triumph for glyco-engineering.Profiling N-linked oligosaccharides from IgG by high-performance anion-exchange chromatography with pulsed amperometric detection.Impact of host cell line choice on glycan profile.Alga-Made Anti-Hepatitis B Antibody Binds to Human Fcγ Receptors.Structural characterization of the Man5 glycoform of human IgG3 Fc.One-pot N-glycosylation remodeling of IgG with non-natural sialylglycopeptides enables glycosite-specific and dual-payload antibody-drug conjugates.Analytical comparability study of recombinant monoclonal antibody therapeutics.Evaluation of analytical similarity between trastuzumab biosimilar CT-P6 and reference product using statistical analyses.

P2860

Q26799266-B7A69686-20D3-47A2-B40E-990358725D48 Q26859713-DC6E377F-DD85-4D21-A324-91834202870E Q27673777-AADC6EA2-9F20-46F2-9534-722433A9E7EA Q28550050-BEBCF4BC-8B0C-4483-B287-892D18F65156 Q30377369-16549A5E-29E8-4770-9FE1-727E5C8E1CA6 Q30675226-0CC62D23-E49B-45F4-94F2-B780092E901D Q35019925-A4040EA1-0C9A-4AF1-BA4C-03B48582BD6C Q36133312-C1DDBBFB-4257-4728-930C-B8C4C3B98861 Q36216323-925794D2-8C25-4442-9B7F-FCC76F395936 Q36239584-85EF6CDB-B408-432C-854E-341674A364E1 Q37138255-729E4EF5-6577-40F7-8667-AE853F618C7F Q38065955-51992A1B-0AF3-43C7-99F3-D3B92240BDAD Q38489049-1020C03D-AC91-408D-8177-C589A350E457 Q38724772-06BBDD28-2145-4D80-97C2-86EF49C87590 Q38762019-F0A5CA00-D128-45AD-A5E9-C794FF0BB691 Q38807919-F4DC4180-CE54-43EF-9F3D-BF30FC8FDDD9 Q38907094-6345F16D-54A8-408A-A26A-3654FE3F88EB Q39062945-9EDF7492-F23C-45FF-ACB7-6C937492F14F Q42333453-305D80DD-DEF7-49E6-952D-9DBD24817470 Q46608396-7A5F4ED7-C69E-4EDB-AFA3-889B204DBCF7 Q47269842-2B8E148A-49CE-4F6F-AF97-E7ACCB2DDF4A Q47341896-E91ACFD8-C618-49B6-B488-423FDE890845 Q47445247-F89B8E70-6A1B-467C-AB51-BCB79AF29A8C Q48987144-6520712A-DDEE-42D6-8DE1-7E725E4771E8 Q52669512-0B20505A-EDFB-4101-8B99-33A4C86CCCF3 Q52684751-EA4CAD13-9DC0-4FEB-AE9F-705C1C9DB814

P2860

Increased serum clearance of oligomannose species present on a human IgG1 molecule.

http://www.wikidata.org/entity/Q36402812

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Increased serum clearance of oligomannose species present on a human IgG1 molecule.

@ast

Increased serum clearance of oligomannose species present on a human IgG1 molecule.

@en

type

label

Increased serum clearance of oligomannose species present on a human IgG1 molecule.

@ast

Increased serum clearance of oligomannose species present on a human IgG1 molecule.

@en

prefLabel

Increased serum clearance of oligomannose species present on a human IgG1 molecule.

@ast

Increased serum clearance of oligomannose species present on a human IgG1 molecule.

@en

P1433

Q36402812-226A36D3-6A46-47A2-AD5A-0C086D0F45C4

P1476

Q36402812-4297C614-B179-44EF-81AA-C73939460F81

P2093

Q36402812-841D1925-57B5-489A-A7B3-D67E0C290976

Q36402812-873C32D1-4C4E-4E17-A9F8-E6FAD9C1D508

Q36402812-8CF79859-8DA7-4D92-967A-6BFE6051CE0E

Q36402812-932F9B1E-BC13-4914-BE14-2D612762A063

Q36402812-986C7AD7-C611-4A9E-991A-0D1D5743F99F

Q36402812-ABDDF035-465A-4D0B-8D0E-BA5E9ED5926F

Q36402812-BD0476EF-E9EE-4747-B9BC-3EA437FBE474

Q36402812-EC2DDB43-25B2-4C03-9459-9B7CB42BEEA9

Q36402812-ED30822B-4981-4256-9EE6-949D2872ABAE

P2860

Q36402812-012A8F3C-4F9A-40E9-8CAF-C65D7A3B0FE5

Q36402812-303813E9-655A-4685-8105-BEDFDC75A700

Q36402812-339E14A2-3B73-4D89-8AA4-929C88F4F72C

Q36402812-3646C2F4-5FFE-410F-A867-32954A869D3D

Q36402812-399B7BCF-19F2-4D5D-9631-92582A348001

Q36402812-3FDEC434-706B-4EBE-863E-314AA4509619

Q36402812-4341B08E-6B7B-4497-B5FA-6314319B7990

Q36402812-5BE68E4C-F0A9-42A9-8617-CE49A1692905

Q36402812-6592476A-D88B-42A7-A381-E6F1E258A348

Q36402812-A513E66B-DE50-4CD7-9C77-7A595FE72AD0

P304

Q36402812-7B76553E-FFA4-4A14-8F46-1C3F65AAD5DC

P31

Q36402812-D1A79AF1-EECA-4E59-90D4-E77C13DEBAE0

P356

Q36402812-597E69B3-0D1B-4BDB-8D71-EF4C09A6A94D

P433

Q36402812-1E09C30A-D64C-4611-8CCA-B9C5922DEEE0

P478

Q36402812-B79D626D-3722-4A79-8701-21CB591F2775

P577

Q36402812-44461132-4A68-4E98-84EA-79BE8B5A08F3

P5875

Q36402812-AA4A0BF4-D1BD-4A83-9FE6-F91F400486ED

P698

Q36402812-19BF7213-7BE6-45C1-A619-450FECB0C7F7

P932

Q36402812-E51AE686-B90E-43B9-BCA7-B1E7F48A2130

P356

P1433

Monoclonal Antibodies

P1476

Increased serum clearance of oligomannose species present on a human IgG1 molecule.

@en

P2093

Aima Acquah

http://www.w3.org/2001/XMLSchema#string

Czeslaw Radziejewski

http://www.w3.org/2001/XMLSchema#string

David Leblond

http://www.w3.org/2001/XMLSchema#string

David Ouellette

http://www.w3.org/2001/XMLSchema#string

Ivan Correia

http://www.w3.org/2001/XMLSchema#string

Leslie Alessandri

http://www.w3.org/2001/XMLSchema#string

Mary Saltarelli

http://www.w3.org/2001/XMLSchema#string

Mathew Rieser

http://www.w3.org/2001/XMLSchema#string

Taro Fujimori

http://www.w3.org/2001/XMLSchema#string

P2860

Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose

Mannose receptor-mediated regulation of serum glycoprotein homeostasis

Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds

High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans.

Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys.

The asialoglycoprotein receptor: relationships between structure, function, and expression.

The mannose receptor and other macrophage lectins.

From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor.

Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.

Stability of IgG isotypes in serum.

P304

509-520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/MABS.20450

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225272972

http://www.w3.org/2001/XMLSchema#string

P698

22669558

http://www.w3.org/2001/XMLSchema#string

P932

3499345

http://www.w3.org/2001/XMLSchema#string